-
Something wrong with this record ?
The importance of serum levels of selected biological parameters in the diagnosis, staging and prognosis of multiple myeloma
V. Scudla, T. Pika, M. Budikova, J. Petrova, J. Minarik, J. Bacovsky, K. Langova, J. Zivna
Language English Country Slovakia
Document type Journal Article, Research Support, Non-U.S. Gov't
Grant support
NR9489
MZ0
CEP Register
NR9500
MZ0
CEP Register
- MeSH
- Diagnosis, Differential MeSH
- Adult MeSH
- Enzyme-Linked Immunosorbent Assay MeSH
- Hepatocyte Growth Factor blood MeSH
- Collagen Type I MeSH
- Middle Aged MeSH
- Humans MeSH
- Multiple Myeloma blood diagnosis MeSH
- Monoclonal Gammopathy of Undetermined Significance blood diagnosis MeSH
- Biomarkers, Tumor blood MeSH
- Osteoprotegerin blood MeSH
- Peptide Fragments blood MeSH
- Peptides MeSH
- Prognosis MeSH
- Procollagen blood MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Neoplasm Staging MeSH
- Syndecan-1 blood MeSH
- Vascular Endothelial Growth Factor A blood MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
The study aimed at evaluating the relation of 7 parameters associated with the internal biological properties of myeloma cells and the bone marrow microenvironment to multiple myeloma (MM) stages, distinguishing its initial/asymptomatic phase from monoclonal gammopathy of undetermined significance (MGUS) and assessing their relation to myeloma prognosis. In the studied group comprising 286 individuals (89 MGUS and 179 MM patients), statistically significant differences (Mann-Whitney test) between MGUS and MM at the time of diagnosis were found in the serum levels of HGF (hepatocyte growth factor), VEGF (vascular endothelial growth factor), ICTP (intercellular - carboxy-terminal telopeptide of type I collagen), PINP (procollagen type I N-terminal propeptide), OPG (osteoprotegerin) and syndecan-1/CD138, but not in Fas. Multivariate analysis (logistic regression) revealed an unsatisfactory potential of all the 7 studied indicators to discriminate between MGUS and MM. A deeper analysis showed statistically significant differences between MGUS and the initial/asymptomatic phase of MM (stage 1 according to the International Staging System) only in the cases of syndecan-1 (p=0.001) and Fas (p=0.008). The assessment of initial values of HGF, VEGF, ICTP, PINP, OPG, syndecan-1 and Fas showed a statistically significant relation (log rank test) to the overall survival (OS) in a group of 132 patients treated with conventional chemotherapy only in the cases of syndecan-1 (p=0.0002) and Fas (p=0.018), but in none of the investigated parameters in a group of 74 patients treated with HDT/ASCT (high-dose therapy/autologous stem cell transplantation). The analysis showed that, despite significant differences in serum levels of 6 of the 7 studied parameters found between MGUS and MM, none of the markers may be included in the spectrum of indicators used to distinguish the two conditions. Despite the positive relation, especially of syndecan-1 and, to a lesser extent, of Fas to the OS in patients treated with conventional chemotherapy, these prognostic factors are not applicable to HDT/ASCT.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc12025271
- 003
- CZ-PrNML
- 005
- 20140724112908.0
- 007
- ta
- 008
- 120816s2010 xo f 000 0#eng||
- 009
- AR
- 024 7_
- $a 10.4149/neo_2010_02_102 $2 doi
- 035 __
- $a (PubMed)20099972
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xo
- 100 1_
- $a Ščudla, Vlastimil, $d 1946- $7 jn20000402953 $u Department of Internal Medicine III, University Hospital, Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic. vlastimil.scudla@fnol.cz
- 245 14
- $a The importance of serum levels of selected biological parameters in the diagnosis, staging and prognosis of multiple myeloma / $c V. Scudla, T. Pika, M. Budikova, J. Petrova, J. Minarik, J. Bacovsky, K. Langova, J. Zivna
- 520 9_
- $a The study aimed at evaluating the relation of 7 parameters associated with the internal biological properties of myeloma cells and the bone marrow microenvironment to multiple myeloma (MM) stages, distinguishing its initial/asymptomatic phase from monoclonal gammopathy of undetermined significance (MGUS) and assessing their relation to myeloma prognosis. In the studied group comprising 286 individuals (89 MGUS and 179 MM patients), statistically significant differences (Mann-Whitney test) between MGUS and MM at the time of diagnosis were found in the serum levels of HGF (hepatocyte growth factor), VEGF (vascular endothelial growth factor), ICTP (intercellular - carboxy-terminal telopeptide of type I collagen), PINP (procollagen type I N-terminal propeptide), OPG (osteoprotegerin) and syndecan-1/CD138, but not in Fas. Multivariate analysis (logistic regression) revealed an unsatisfactory potential of all the 7 studied indicators to discriminate between MGUS and MM. A deeper analysis showed statistically significant differences between MGUS and the initial/asymptomatic phase of MM (stage 1 according to the International Staging System) only in the cases of syndecan-1 (p=0.001) and Fas (p=0.008). The assessment of initial values of HGF, VEGF, ICTP, PINP, OPG, syndecan-1 and Fas showed a statistically significant relation (log rank test) to the overall survival (OS) in a group of 132 patients treated with conventional chemotherapy only in the cases of syndecan-1 (p=0.0002) and Fas (p=0.018), but in none of the investigated parameters in a group of 74 patients treated with HDT/ASCT (high-dose therapy/autologous stem cell transplantation). The analysis showed that, despite significant differences in serum levels of 6 of the 7 studied parameters found between MGUS and MM, none of the markers may be included in the spectrum of indicators used to distinguish the two conditions. Despite the positive relation, especially of syndecan-1 and, to a lesser extent, of Fas to the OS in patients treated with conventional chemotherapy, these prognostic factors are not applicable to HDT/ASCT.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a senioři nad 80 let $7 D000369
- 650 _2
- $a kolagen typu I $7 D024042
- 650 _2
- $a diferenciální diagnóza $7 D003937
- 650 _2
- $a ELISA $7 D004797
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a hepatocytární růstový faktor $x krev $7 D017228
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a monoklonální gamapatie nejasného významu $x krev $x diagnóza $7 D008998
- 650 _2
- $a mnohočetný myelom $x krev $x diagnóza $7 D009101
- 650 _2
- $a staging nádorů $7 D009367
- 650 _2
- $a osteoprotegerin $x krev $7 D053244
- 650 _2
- $a peptidové fragmenty $x krev $7 D010446
- 650 _2
- $a peptidy $7 D010455
- 650 _2
- $a prokolagen $x krev $7 D011347
- 650 _2
- $a prognóza $7 D011379
- 650 _2
- $a syndekan-1 $x krev $7 D053668
- 650 _2
- $a nádorové biomarkery $x krev $7 D014408
- 650 _2
- $a vaskulární endoteliální růstový faktor A $x krev $7 D042461
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Pika, Tomáš $7 xx0071238 $u Department of Internal Medicine III, University Hospital, Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic
- 700 1_
- $a Budíková, Marie $7 xx0172938 $u Department of Clinical Biochemistry, University Hospital, Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic
- 700 1_
- $a Petrová, J $u Department of Clinical Biochemistry, University Hospital, Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic
- 700 1_
- $a Minařík, Jiří $7 xx0106330 $u Department of Internal Medicine III, University Hospital, Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic
- 700 1_
- $a Bačovský, Jaroslav $7 xx0053311 $u Department of Internal Medicine III, University Hospital, Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic
- 700 1_
- $a Langová, Kateřina $7 xx0141371 $u Department of Medical Biophysics, University Hospital, Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic
- 700 1#
- $a Živná, Jarmila, $d 1953- $7 xx0208844 $u Department of Haematology, Hranice Hospital, Czech Republic
- 773 0_
- $w MED00003470 $t Neoplasma $x 0028-2685 $g Roč. 57, č. 2 (2010), s. 102-110
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/20099972 $y Pubmed
- 910 __
- $a ABA008 $b A 1194 $c 659 $y m $z 0
- 990 __
- $a 20120816 $b ABA008
- 991 __
- $a 20140724113219 $b ABA008
- 999 __
- $a ok $b bmc $g 947313 $s 782617
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2010 $b 57 $c 2 $d 102-110 $i 0028-2685 $m Neoplasma $n Neoplasma $x MED00003470
- GRA __
- $a NR9489 $p MZ0
- GRA __
- $a NR9500 $p MZ0
- LZP __
- $a Pubmed-20120816/10/02